ES2080031T3 - Preparacion oftalmologica. - Google Patents

Preparacion oftalmologica.

Info

Publication number
ES2080031T3
ES2080031T3 ES93917820T ES93917820T ES2080031T3 ES 2080031 T3 ES2080031 T3 ES 2080031T3 ES 93917820 T ES93917820 T ES 93917820T ES 93917820 T ES93917820 T ES 93917820T ES 2080031 T3 ES2080031 T3 ES 2080031T3
Authority
ES
Spain
Prior art keywords
ophthalmological preparation
formulation
ophthalmological
preparation
pilocarpine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93917820T
Other languages
English (en)
Other versions
ES2080031T1 (es
Inventor
Kari Lehmussaari
Olli Oksala
Timo Reunamaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Oy
Original Assignee
Santen Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Oy filed Critical Santen Oy
Publication of ES2080031T1 publication Critical patent/ES2080031T1/es
Application granted granted Critical
Publication of ES2080031T3 publication Critical patent/ES2080031T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Laser Surgery Devices (AREA)
  • Radiation-Therapy Devices (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UNA FORMULACION DE GOTAS PARA LOS OJOS, QUE,EN COMBINACION, COMPRENDE PILOCARPINA Y UN AGENTE ADICIONAL PARA EL TRATAMIENTO DE HIPERTENSION OCULAR, ASI COMO UN PORTADOR ACEPTABLE OFTALMOLOGICAMENTE Y OPCIONALMENTE AYUDANTES OFTALMOLOGICAMENTE ACEPTABLE. LA FORMULACION SE CARACTERIZA EN QUE EL PH DE ESTA ES DE 3.5 A 5.8 Y LA VISCOSIDAD ES DE 10 A 25000 MPAS. LA INVENCION TAMBIEN SE REFIERE A LA PREPARACION DE DICHA FORMULACION, ASI COMO SU USO PARA EL TRATAMIENTO DE HIPERTENSION OCULAR Y GLAUCOMA.
ES93917820T 1992-08-20 1993-08-18 Preparacion oftalmologica. Expired - Lifetime ES2080031T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9202398A SE512871C2 (sv) 1992-08-20 1992-08-20 Oftalmologisk beredning innehållande pilokarpin och ytterligare medel för behandling av okular hypertension

Publications (2)

Publication Number Publication Date
ES2080031T1 ES2080031T1 (es) 1996-02-01
ES2080031T3 true ES2080031T3 (es) 1999-05-01

Family

ID=20386970

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93917820T Expired - Lifetime ES2080031T3 (es) 1992-08-20 1993-08-18 Preparacion oftalmologica.

Country Status (27)

Country Link
US (1) US5767143A (es)
EP (1) EP0655911B1 (es)
JP (1) JPH08500354A (es)
KR (1) KR100295407B1 (es)
CN (1) CN1041795C (es)
AT (1) ATE175867T1 (es)
AU (1) AU674335B2 (es)
BG (1) BG62381B1 (es)
BR (1) BR9307099A (es)
CZ (1) CZ283895B6 (es)
DE (2) DE655911T1 (es)
DK (1) DK0655911T3 (es)
EE (1) EE03188B1 (es)
ES (1) ES2080031T3 (es)
GR (2) GR960300003T1 (es)
HK (1) HK1013955A1 (es)
HU (1) HU226829B1 (es)
MX (1) MX9305043A (es)
NO (1) NO307952B1 (es)
PL (1) PL175860B1 (es)
RO (1) RO111988B1 (es)
SE (1) SE512871C2 (es)
SG (1) SG49041A1 (es)
SK (1) SK281092B6 (es)
TW (1) TW427913B (es)
WO (1) WO1994004134A1 (es)
ZA (1) ZA936094B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0929292B1 (en) * 1996-09-20 2001-05-30 Bausch & Lomb Incorporated Method and composition for rewetting contact lenses and relieving eye dryness
WO1999022715A1 (en) * 1997-11-05 1999-05-14 Senju Pharmaceutical Co., Ltd. Sustained release eyedrops
US6335335B2 (en) 1997-11-05 2002-01-01 Senju Pharmaceutical Co., Ltd. Prolonged-action eye drop
MY116782A (en) 1997-12-22 2004-03-31 Otsuka Pharma Co Ltd Water-soluble eye drop
JP2005247875A (ja) * 2000-07-21 2005-09-15 Rohto Pharmaceut Co Ltd 点眼剤
JP2002097129A (ja) * 2000-07-21 2002-04-02 Rohto Pharmaceut Co Ltd 点眼剤
JP5364658B2 (ja) * 2000-07-21 2013-12-11 ロート製薬株式会社 点眼剤
AU2002245134A1 (en) * 2000-12-21 2002-08-06 Alcon Universal Ltd. Artificial tear composition adapted to be used with contact lenses
CN100483106C (zh) * 2002-09-29 2009-04-29 天津市先石光学技术有限公司 可分离介质表层与深层信息的光学检测方法
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
WO2009110009A2 (en) * 2008-03-07 2009-09-11 Sun Pharma Advanced Research Company Ltd., Opthalmic composition
MY168643A (en) 2011-09-20 2018-11-27 Allergan Inc Compositions and methods for treating presbyopia, mild hyperopia, and irregular astigmatism
EP3681500B1 (en) 2018-04-24 2022-03-23 Allergan, Inc. Use of pilocarpine hydrochloride for the treatment of presbyopia
WO2023234423A1 (en) * 2022-06-03 2023-12-07 Amd Therapeutics Llc Rifamycin ophthalmic composition and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601247A1 (fr) * 1986-07-09 1988-01-15 Merk Sharp Dohme Chibret Labor Combinaison d'agents beta-bloquants et de pilocarpine.
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use

Also Published As

Publication number Publication date
TW427913B (en) 2001-04-01
EP0655911B1 (en) 1999-01-20
GR3029992T3 (en) 1999-07-30
ES2080031T1 (es) 1996-02-01
HU9500501D0 (en) 1995-04-28
HUT71897A (en) 1996-02-28
WO1994004134A1 (en) 1994-03-03
DE69323202T2 (de) 1999-07-01
US5767143A (en) 1998-06-16
CN1041795C (zh) 1999-01-27
KR100295407B1 (ko) 2001-09-17
NO950595D0 (no) 1995-02-17
AU674335B2 (en) 1996-12-19
EP0655911A1 (en) 1995-06-07
SE512871C2 (sv) 2000-05-29
RO111988B1 (ro) 1997-04-30
BR9307099A (pt) 1999-06-01
GR960300003T1 (en) 1996-02-29
PL307526A1 (en) 1995-05-29
CZ283895B6 (cs) 1998-07-15
EE03188B1 (et) 1999-06-15
SK20995A3 (en) 1997-01-08
SE9202398D0 (sv) 1992-08-20
DE69323202D1 (de) 1999-03-04
NO950595L (no) 1995-02-17
BG62381B1 (bg) 1999-10-29
CZ41495A3 (en) 1995-10-18
AU4711793A (en) 1994-03-15
ATE175867T1 (de) 1999-02-15
HU226829B1 (en) 2009-11-30
JPH08500354A (ja) 1996-01-16
NO307952B1 (no) 2000-06-26
BG99483A (bg) 1995-12-29
CN1089837A (zh) 1994-07-27
DK0655911T3 (da) 1999-09-13
MX9305043A (es) 1994-02-28
DE655911T1 (de) 1996-02-29
HK1013955A1 (en) 1999-09-17
PL175860B1 (pl) 1999-02-26
SE9202398L (sv) 1994-02-21
SK281092B6 (sk) 2000-11-07
ZA936094B (en) 1994-03-28
SG49041A1 (en) 1998-05-18

Similar Documents

Publication Publication Date Title
ES2080031T3 (es) Preparacion oftalmologica.
WO1997028827A1 (fr) Composition ophtalmique possedant une viscosite adaptee
ES2172242T3 (es) Composiciones oftalmicas de liberacion mantenida conteniendo medicamentos solubles en agua.
CA2236582A1 (en) Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
GEP20002331B (en) Alkylated Raphamicine Derivatives
MX9702349A (es) Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma.
EP0879601A3 (en) Ophthalmic drug delivery system
MX203891B (es) Compuestos funcionales de 1, 3-dicetoamida etilenicamente insaturados, polimeros de los mismos y formulaciones de latex que contienen los mismos
EP0045617A3 (en) Pharmaceutical composition
MY106109A (en) 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions
DK0562445T3 (da) Gel, især oftalmisk
DE69829062D1 (de) Verwendung von flunarizin zur topischen behandlung ocularem hochdruck
IE831030L (en) Benzopyrans and benzothiopyrans
KR880001290A (ko) β-차단제 및 필로카르핀-함유 제제
EP0122178A3 (en) Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
WO1992010473A3 (en) 2-decarboxyl-2-alkoxyalkyl prostaglandins as ocular hypotensives
CA2067395A1 (en) Antimetastatically acting agents
RU97118811A (ru) Способ лечения первичной открытоугольной глаукомы

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 655911

Country of ref document: ES